title: [Coenzyme q10 in complex therapy of patients with ischemic heart disease].
abstract: The paper contains results of assessment of clinical efficacy and safety of coenzyme Q10 in patients with ischemic heart disease. Coenzyme Q10 (60 mg/day for 8 weeks) added to basic treatment of patients with stable class II-III angina significantly improved clinical status of these patients without clinically significant side effects.
authors.affiliation: Novosibirsk State Medical University, Krasny Prospect, 52, 630091 Novosibirsk, Russia.
authors.forename: A D
authors.initials: AD
authors.lastname: Kuimov
authors.forename: T A
authors.initials: TA
authors.lastname: Murzina
mesh_terms: D000328:Adult; D000368:Aged; D060050:Angina, Stable / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology / Q000523:psychology; D001526:Behavioral Symptoms / Q000188:drug therapy*; D001786:Blood Glucose; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000009:adverse effects; D016903:Drug Monitoring; D017079:Exercise Tolerance / Q000187:drug effects; D005260:Female; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D012720:Severity of Illness Index; D063189:Symptom Assessment; D016896:Treatment Outcome; D014451:Ubiquinone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D014815:Vitamins / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D001786:Blood Glucose; D002317:Cardiovascular Agents; D014815:Vitamins; D014451:Ubiquinone; C024989:coenzyme Q10